Literature DB >> 21620475

Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications.

Johanna M Seddon1, Robyn Reynolds, Heeral R Shah, Bernard Rosner.   

Abstract

OBJECTIVE: We evaluated monozygotic twin pairs with discordant age-related macular degeneration (AMD) phenotypes to assess differences in behavioral and nutritional factors.
DESIGN: Case series. PARTICIPANTS: Caucasian male twin pairs from the United States Twin Study of Macular Degeneration.
METHODS: Twin pairs were genotyped to confirm monozygosity. Ocular characteristics were evaluated based on fundus photographs using the Wisconsin Grading System and a 5-grade Clinical Age-Related Maculopathy Staging System. We selected twin pairs discordant in each of the following phenotypic categories: Stage of AMD (n = 28), drusen area (n = 60), drusen size (n = 40), and increased pigment area (n = 56). The Wilcoxon signed-rank test and linear regression were used to assess associations between behavioral and nutritional characteristics and each phenotype within discordant twin pairs. MAIN OUTCOME MEASURES: Differences in smoking and dietary factors within twin pairs discordant for stage of AMD, drusen area, drusen size, and pigment area.
RESULTS: Representative fundus photographs depict the discordant phenotypes. Pack-years of smoking were higher for the twin with the more advanced stage of AMD (P = 0.05). Higher dietary intake of vitamin D was present in the twins with less severe AMD (P = 0.01) and smaller drusen size (P = 0.05) compared with co-twins, adjusted for smoking and age. Dietary intakes of betaine and methionine were significantly higher in the twin with lower stage of AMD (P = 0.009) and smaller drusen area (P = 0.03), respectively.
CONCLUSIONS: The twin with the more advanced stage of AMD, larger drusen area, drusen size, and pigment area tended to be the heavier smoker. The twin with the earlier stage of AMD, smaller drusen size and area, and less pigment tended to have higher dietary vitamin D, betaine, or methionine intake. Results suggest that behavioral and nutritional factors associated with epigenetic mechanisms are involved in the etiology of AMD, in addition to genetic susceptibility.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620475      PMCID: PMC3711586          DOI: 10.1016/j.ophtha.2010.12.020

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  52 in total

1.  Genetic influence on early age-related maculopathy: a twin study.

Authors:  Christopher J Hammond; Andrew R Webster; Harold Snieder; Alan C Bird; Clare E Gilbert; Tim D Spector
Journal:  Ophthalmology       Date:  2002-04       Impact factor: 12.079

2.  Studies on similarity diagnosis in twins with the aid of mailed questionnaires.

Authors:  R CEDERLOF; L FRIBERG; E JONSSON; L KAIJ
Journal:  Acta Genet Stat Med       Date:  1961

3.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

4.  Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994.

Authors:  Niyati Parekh; Richard J Chappell; Amy E Millen; Daniel M Albert; Julie A Mares
Journal:  Arch Ophthalmol       Date:  2007-05

5.  Genetic risk of age-related maculopathy. Population-based familial aggregation study.

Authors:  C C Klaver; R C Wolfs; J J Assink; C M van Duijn; A Hofman; P T de Jong
Journal:  Arch Ophthalmol       Date:  1998-12

6.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration.

Authors:  Mingyao Li; Pelin Atmaca-Sonmez; Mohammad Othman; Kari E H Branham; Ritu Khanna; Michael S Wade; Yun Li; Liming Liang; Sepideh Zareparsi; Anand Swaroop; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2006-08-27       Impact factor: 38.330

Review 7.  The study of human twins in medical research.

Authors:  Z Hrubec; C D Robinette
Journal:  N Engl J Med       Date:  1984-02-16       Impact factor: 91.245

8.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

9.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

10.  Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.

Authors:  Johanna M Seddon; Robyn Reynolds; Bernard Rosner
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

View more
  32 in total

1.  Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration.

Authors:  Gwenole Quellec; Stephen R Russell; Johanna M Seddon; Robyn Reynolds; Todd Scheetz; Vinit B Mahajan; Edwin M Stone; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

Review 2.  Vitamin D: Implications for ocular disease and therapeutic potential.

Authors:  Rose Y Reins; Alison M McDermott
Journal:  Exp Eye Res       Date:  2015-02-25       Impact factor: 3.467

3.  Association between vitamin D status and age-related macular degeneration by genetic risk.

Authors:  Amy E Millen; Kristin J Meyers; Zhe Liu; Corinne D Engelman; Robert B Wallace; Erin S LeBlanc; Lesley F Tinker; Sudha K Iyengar; Jennifer G Robinson; Gloria E Sarto; Julie A Mares
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

4.  Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A E Millen; J Nie; M W Sahli; J A Mares; K J Meyers; B E K Klein; M J LaMonte; P L Lutsey; C A Andrews; R Klein
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 5.  Genetic and environmental underpinnings to age-related ocular diseases.

Authors:  Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

6.  A role for epigenetic changes in the development of retinal neurodegenerative conditions.

Authors:  Heather R Pelzel; Robert W Nickells
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-20

7.  Cohort Profile: The National Academy of Sciences-National Research Council Twin Registry (NAS-NRC Twin Registry).

Authors:  Margaret Gatz; Jennifer R Harris; Jaakko Kaprio; Matt McGue; Nicholas L Smith; Harold Snieder; Avron Spiro; David A Butler
Journal:  Int J Epidemiol       Date:  2014-09-01       Impact factor: 7.196

8.  Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals.

Authors:  E J Sigler; J C Randolph; J I Calzada; S Charles
Journal:  Eye (Lond)       Date:  2014-05-16       Impact factor: 3.775

Review 9.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

10.  Prospective study of plasma homocysteine, its dietary determinants, and risk of age-related macular degeneration in men.

Authors:  William G Christen; Nancy R Cook; Stephanie E Chiuve; Paul M Ridker; J Michael Gaziano
Journal:  Ophthalmic Epidemiol       Date:  2017-10-16       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.